Skip to main content

Bethanechol Disease Interactions

There are 6 disease interactions with bethanechol.

Major

Cholinergic agonist (applies to bethanechol) bronchospasm

Major Potential Hazard, High plausibility. Applicable conditions: Asthma

The use of cholinergic agonists is contraindicated in patients with uncontrolled reactive airway disease. Cholinergic agonists inhibits the hydrolysis of acetylcholine. The enhanced effect of acetylcholine produces constriction of the bronchi, increased bronchial secretions, and bronchospasm.

References

  1. "Product Information. Salagen (pilocarpine)." Boehringer-Ingelheim PROD
  2. "Product Information. Urecholine (bethanechol)." Merck & Co., Inc PROD (2001):
Major

Cholinergic agonist (applies to bethanechol) cardiac dysfunction

Major Potential Hazard, High plausibility. Applicable conditions: Hypotension, Ischemic Heart Disease, Heart Block, Hypertension

The use of cholinergic agonists, such as bethanechol and pilocarpine, is contraindicated in patients with pronounced bradycardia, hypotension/hypertension, coronary artery disease or conduction disorders.

References

  1. "Product Information. Salagen (pilocarpine)." Boehringer-Ingelheim PROD
  2. "Product Information. Urecholine (bethanechol)." Merck & Co., Inc PROD (2001):
Major

Cholinergic agonist (applies to bethanechol) GI/bladder neck obstruction

Major Potential Hazard, High plausibility. Applicable conditions: Colitis/Enteritis (Noninfectious), Gastrointestinal Obstruction, Peptic Ulcer, Urinary Tract Obstruction

The use of cholinergic agonists is contraindicated in patients with peptic ulcers, mechanical GI obstruction, acute GI inflammatory conditions, or urinary obstruction. Cholinergic activity may result in an increase in gastric acid secretion, GI motility, and gastric contractions. In patients with urinary retention, urinary reflux may occur if the sphincter fails to relax when the bladder is contracted by cholinergic stimulation. The reflux of urine from the bladder can cause infection in the kidneys and upper urinary tract if bacteriuria is present.

References

  1. "Product Information. Salagen (pilocarpine)." Boehringer-Ingelheim PROD
  2. "Product Information. Urecholine (bethanechol)." Merck & Co., Inc PROD (2001):
Major

Cholinergic agonist (applies to bethanechol) hyperthyroidism

Major Potential Hazard, High plausibility.

The use of cholinergic agents may be contraindicated in patients with hyperthyroidism. Atrial fibrillation has occurred in hyperthyroid patients administered a cholinergic agonist.

References

  1. "Product Information. Salagen (pilocarpine)." Boehringer-Ingelheim PROD
  2. "Product Information. Urecholine (bethanechol)." Merck & Co., Inc PROD (2001):
Major

Cholinergic agonist (applies to bethanechol) parkinsonism

Major Potential Hazard, High plausibility.

The use of cholinergic agonists may be contraindicated in patients with parkinsonism. Cholinergic agonists directly stimulates the parasympathetic nervous system inducing acetylcholinergic effects. Symptoms of Parkinson's disease may be exacerbated.

References

  1. "Product Information. Salagen (pilocarpine)." Boehringer-Ingelheim PROD
  2. "Product Information. Urecholine (bethanechol)." Merck & Co., Inc PROD (2001):
Major

Cholinergic agonist (applies to bethanechol) seizure disorders

Major Potential Hazard, High plausibility. Applicable conditions: Seizures

The use of cholinergic agonists may be contraindicated in patients with seizure disorders. Cholinomimetics have been associated with convulsions.

References

  1. "Product Information. Salagen (pilocarpine)." Boehringer-Ingelheim PROD
  2. "Product Information. Urecholine (bethanechol)." Merck & Co., Inc PROD (2001):

Bethanechol drug interactions

There are 59 drug interactions with bethanechol.

Bethanechol alcohol/food interactions

There is 1 alcohol/food interaction with bethanechol.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer